FDA Sticks Breakthrough Tag on GlaxoSmithKline's Blood Cancer Drug Post author:Sam Post published:November 1, 2017 Post category:BioPharma GSK2857916 is an anti B-cell maturation agent (BCMA) monoclonal antibody-drug conjugate. Source: BioSpace You Might Also Like The 7 Best Life Science Companies to Work for in 2018 January 10, 2018 Bay Area???s Ardelyx Slashes 28% of Workforce in Restructuring August 8, 2017 Seegene Enters The U.S. Diagnostic Market In Collaboration With Thermo Fisher Scientific May 22, 2017
Seegene Enters The U.S. Diagnostic Market In Collaboration With Thermo Fisher Scientific May 22, 2017
